Overall survival of breast cancer has improved for everyone in the U.S. in recent years, but the pace isn’t the same for all groups of people. Some groups still experience dramatic disparities. For example, according to the American Cancer Society: Dana-Farber wants to close these gaps so that everyone benefits equally from high-quality care and … Read more
Clinical trials assess new medicines to ensure they are safe and effective and to find out which patients they are most likely to benefit. However, clinical trials often enroll few people of color for a constellation of reasons related to historical marginalization of certain groups. Systemic marginalization can result in lower levels of income, fewer … Read more
When Sandra Noack returned home from a visit to Bogota, Colombia, to visit her family, there was a letter waiting for her. It was a leaflet sent via the Massachusetts Department of Public Health describing a clinical trial at Dana-Farber Cancer Institute for Latina and Hispanic breast cancer survivors. The trial didn’t involve any medicine. … Read more
Runners call it Heartbreak Hill, but for Michelle O’Brien the long, rising stretch of pavement that crosses the 20-mile point of the Boston Marathon® route represents the top of the mountain. Just over three years after being diagnosed in back-to-back months with two unrelated cancers — invasive breast cancer in December 2020, and then stage … Read more
Thirteen years after Vici Robinson was treated for estrogen receptor-positive breast cancer, she began experiencing shortness of breath. Her local physicians in New Hampshire determined her symptoms came from liquid that was filling her lung. Then came the shocking news that this was caused by a breast cancer recurrence which had metastasized. At 81, Robinson … Read more
When Meghan MacDonald visited her primary care provider in the fall of 2022 to get a lump in her breast examined, they confirmed her suspicion that it was just an inflamed cyst. Relieved, MacDonald began a course of antibiotics, but when the lump didn’t go away, her doctor ordered a mammogram, and when the results … Read more
Ruth Nelson struggled with her new breast cancer diagnosis mentally and physically. On treatment, her cardiac health faltered, her blood pressure spiked, and she experienced an unexplained episode in which she briefly lost her speech. And on top of that, she felt as if she were “a problem to be managed” by her friends and … Read more
After treatment at Dana-Farber, Dena Ofengeim was able to get on her bike, train with her friends, and complete the Pan-Mass Challenge.
Over the past 30 years, outcomes have improved dramatically for women with breast cancer. There are many new treatments, including hormone therapies and CDK4/6 inhibitors. In contrast, there has been no improvement in the outcomes for men with breast cancer. And current guidelines don’t support the use of newer therapies in men. “If we do … Read more
As a veteran scuba diver who has donned her wetsuit around the globe, Stephanie Lafontaine is never more at peace than when deep below the water’s surface. Even if she’s sharing the depths with sharks, she considers it her happy place. So when Lafontaine, 42, learned in April 2019 that she had inflammatory breast cancer … Read more
Sally Johnston cannot be slowed down. She just recently returned from a month-long trip to South Africa for a safari, and Namibia to visit a longtime friend, and is already planning her next excursion. The 74-year-old survivor has always been active, and she says it’s time to achieve her goal of visiting all seven continents. … Read more
Investigators who run investigator-initiated trials (IITs) have two essential qualities. One is curiosity, which keeps them alert, aware of discoveries, and able to make connections that lead to new treatment ideas. The second is determination. “The burden of responsibility for what is typically a many-year-long study falls on that one investigator,” says Ursula Matulonis, MD, … Read more
A frequent component of treatment for breast cancer is surgery to remove the cancer. While mastectomy was more common in decades past, experts at Dana-Farber want you to know that science and treatment have advanced. Improved screening, early diagnosis, and advances in medicine are enabling many more patients to have the option of breast-conserving surgery, … Read more
Laura Orfanedes was worried that she was going to end up with breast cancer. No one in her family had it, and yet she could not shake the feeling. So she took action. She went in for her first mammogram at age 40. In December 2009, at age 43, her annual scan showed an area … Read more
The trip from Nantucket to Boston, involving a long drive and ferry ride, is an arduous four-hour journey (not counting summer traffic). But when Nantucket resident and retired educator, Claudia Kilvert, was diagnosed with breast cancer, she committed to regularly getting in the car with her husband and 80-pound golden retriever Luna to get treatment … Read more
Breast cancer is one of the most common forms of cancer and affects almost 300,000 women in the United States every year. The good news is that with early detection, the chances of successful treatment are higher. This is why breast cancer screening — which uses tests and imaging to detect cancer in people without … Read more
People who inherit mutations in the BRCA1 or BRCA2 gene are at heightened risk for a variety of cancers, including breast, ovarian, prostate, and pancreatic. It’s estimated that one in 300-400 people in the general population carry a mutation in either of these genes. Among people of Ashkenazi (Eastern European) Jewish descent, the prevalence is … Read more
During a long career in the food industry, Susan Greelish, 64, has prided herself on forming strong, familial-like bonds with her colleagues and customers. When it came to her treatment for breast cancer and kidney cancer, however, these feelings of kinship and trust were missing — until she found her newest family just a few … Read more
In a branch of the PI3K protein family — with members named PI3Kα, PI3Kβ, PI3Kδ, and PI3Kγ — PI3Kβ was long treated as the proverbial middle child: neglected by cancer scientists in favor of its more prominent siblings. In a new study, Dana-Farber researchers demonstrate that it doesn’t deserve its obscurity — that in fact … Read more
By Valerie Frank Ever since I can remember, I’ve made people laugh. I was always the funny friend, and when I was in my mid-20s I made it official by becoming a Main Stage cast member of ImprovBoston — an improvisational comedy theater in Cambridge, MA. Once I retired from improv to become a suburban … Read more